Medication-Assisted Treatment Approaches for Alcohol and Opioid Use Disorder (MAT-A)

Overview
The purpose of this training is to provide participants with a detailed overview of medications that have been shown to be effective as a component of the treatment of alcohol and opioid use disorders. Topics will include: the context for medication assisted treatment (positive and negative perceptions), the epidemiology of alcohol and opioid use and dependence (user demographics), a review of the various classes of opioids, an overview of each medication, its indication, to whom it is administered, and how it works, and treatment settings for medication-assisted treatment. Medications will include: acamprosate, disulfiram, naltrexone, methadone, and buprenorphine. The training will conclude with a session on talking to clients about their use of medications, and strategies to address health disparities through increased access to medication-assisted treatment. Recorded on March 18, 2021.
Learning objectives
- Propose at least three (3) acute and chronic effects of alcohol, heroin, and other opioids
- Identify the prevalence of and at least three (3) key populations impacted by alcohol and opioid use disorders
- Specify three (3) medications that are available to treat alcohol and opioid use disorders
- Apply at least two (2) strategies that can be used to address health disparities through increased access to medication-assisted treatment
- Determine and describe the mechanism of action of one (1) medication that can reverse overdose in individuals who use opioids